Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSFS.L Regulatory News (CSFS)

  • There is currently no data for CSFS

Hardman Research: Cornerstone FS - FY21 update

19 Jan 2022 07:15

RNS Number : 8782Y
Cornerstone FS PLC
19 January 2022
 

Hardman & Co Research on: Cornerstone FS (CSFS)

FY21 update: ahead of market expectations

Cornerstone is experiencing strong growth, benefiting particularly from favourable underlying market trends and from the expansion of its Asia-focused operations during FY21. The trading update for FY21 to end-December confirms strong revenue momentum (38% year-on-year growth) and an emphatic 21.7% point YoY uplift in gross margin. The margin uplift was driven by higher customer revenue through direct channels (c.56% of total revenue in FY21), versus the indirect introducer network, although all channels saw growth. With a coherent product development roadmap in place and a strong pipeline of acquisitions, Cornerstone should continue to deliver solid growth over the medium term.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/fy21-update-ahead-of-market-expectations/ 

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Milan Radia

+44(0)20 3693 7075

 

mr@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFALIITLIF
Date   Source Headline
8th May 20247:00 amRNSFinal Results, Annual Report & AGM Notice
16th Apr 20247:00 amRNSNotice of Results and Investor Presentation
15th Apr 20249:41 amRNSHolding(s) in Company
20th Mar 20249:49 amRNSProposed change of name to Finseta plc
4th Mar 20247:00 amRNSAppointment of Nominated Adviser and Broker
23rd Feb 20247:00 amRNSGrant of Options, PDMR Dealing
13th Feb 20247:00 amRNSReceipt of Regulatory Licence in Canada
7th Feb 20248:21 amRNSHolding(s) in Company
31st Jan 202411:57 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAgreement with Mastercard
18th Jan 20243:07 pmRNSChange of Registered Office
10th Jan 202410:19 amRNSHolding(s) in Company
10th Jan 20247:00 amRNS2023 Full Year Trading Update
4th Dec 20237:00 amRNSFY 2023 trading above current market expectations
17th Nov 20237:00 amRNSGrant and Cancellation of Options; PDMR Dealings
14th Nov 20232:09 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSTrading Update - Continued strong trading momentum
16th Oct 20237:00 amRNSHolding(s) in Company
20th Sep 20235:17 pmRNSSale of Non-Trading Subsidiary
12th Sep 20237:00 amRNSInterim Results
29th Aug 20237:00 amRNSNotice of Interim Results and Webinar
11th Jul 20237:00 amRNSRevenue growth & adj. EBITDA positive for H1 23
7th Jul 20236:11 pmRNSHolding(s) in Company
4th Jul 20237:00 amRNSChange of Adviser
20th Jun 20232:55 pmRNSResult of AGM
22nd May 202311:13 amRNSHolding(s) in Company
16th May 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
12th May 20231:44 pmRNSInvestor Presentation via Investor Meet Company
11th May 202311:33 amRNSHolding(s) in Company
2nd May 202310:53 amRNSNotice of Final Results
27th Apr 20237:00 amRNSCompletion of Sale of Avila House Ltd.
19th Apr 20237:00 amRNSTrading Update
13th Mar 20237:00 amRNSNo Exposure / Affiliation with Silicon Valley Bank
8th Mar 20237:00 amRNSVariation of Incentivisation & Settlement Arr.
16th Feb 20236:15 pmRNSHolding(s) in Company
16th Feb 20236:08 pmRNSHolding(s) in Company
16th Feb 20235:45 pmRNSHolding(s) in Company
16th Feb 20235:38 pmRNSHolding(s) in Company
13th Feb 20238:01 amRNSHolding(s) in Company
6th Feb 20237:00 amRNSPDMR Shareholding, Issue of Equity and TVR
26th Jan 20235:19 pmRNSHolding(s) in Company
26th Jan 20234:25 pmRNSHolding(s) in Company
25th Jan 20235:36 pmRNSHolding(s) in Company
23rd Jan 202310:02 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSDirectors'/PDMR Shareholdings
17th Jan 202310:29 amRNSDirector/PDMR Shareholding
16th Jan 20237:00 amEQSHardman & Co Research on Cornerstone FS (CSFS): Strong FY22 update and Avila House divestment
16th Jan 20237:00 amRNSIssue of Equity, PDMR Dealings, Option Grants, TVR
11th Jan 20237:00 amRNSTrading Update - Ahead of Expectations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.